|
|
Volumn 3, Issue 10, 2011, Pages 1289-1306
|
|
Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIPROTOZOAL AGENT;
CATECHOL;
CATECHOL DERIVATIVE;
ISOBUTYLMETHYLXANTHINE;
PHOSPHODIESTERASE;
PHOSPHODIESTERASE INHIBITOR;
AMINO ACID SEQUENCE;
ARTICLE;
BINDING SITE;
CHEMISTRY;
CLASSIFICATION;
ENZYME ACTIVE SITE;
ENZYMOLOGY;
HUMAN;
LEISHMANIA MAJOR;
METABOLISM;
MOLECULAR GENETICS;
NEGLECTED DISEASE;
SEQUENCE ALIGNMENT;
TRYPANOSOMA BRUCEI;
1-METHYL-3-ISOBUTYLXANTHINE;
AMINO ACID SEQUENCE;
ANTIPROTOZOAL AGENTS;
BINDING SITES;
CATALYTIC DOMAIN;
CATECHOLS;
HUMANS;
LEISHMANIA MAJOR;
MOLECULAR SEQUENCE DATA;
NEGLECTED DISEASES;
PHOSPHODIESTERASE INHIBITORS;
PHOSPHORIC DIESTER HYDROLASES;
SEQUENCE ALIGNMENT;
TRYPANOSOMA BRUCEI BRUCEI;
|
|
EID: 82555177172
PISSN: None
EISSN: 17568927
Source Type: Journal
DOI: 10.4155/fmc.11.77 Document Type: Article |
|
Times cited : (53)
|
|
References (0)
|
